Working… Menu

High-dose Cyclophosphamide for Moderate to Severe Refractory Chronic Inflammatory Demyelinating Polyneuropathy

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01236456
Recruitment Status : Withdrawn (I am relocating to Johns Hopkins Medical Center)
First Posted : November 8, 2010
Last Update Posted : August 12, 2011
Information provided by:
Stony Brook University